SCHULMAN AMY W

Average Profitability
3.04%
Insider Buys Quantity
2
Insider Buys Sum
$10.15M
Insider Sells Quantity
4
Insider Sells Sum
$9.07M

Insider Activity of SCHULMAN AMY W

According to the SEC Form 4 filings, SCHULMAN AMY W, being in a position of

  1. director at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30200 shares for $5.26M,
    over all time since 2024-05-29, has bought 0 shares, and sold 30200 shares for $5.26M.

The largest purchase of all time was on 2019-04-08 and amounted to 626117 shares of Cyclerion Therapeutics, Inc. for $10.02M.

The largest sale of all time was on 2024-05-29 and amounted to 21700 shares of Alnylam Pharmaceuticals, Inc. for $3.22M.

Biography of SCHULMAN AMY W

No biography is available at this moment.

2024-06-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
8,500
0.0067%
$240.00$2.04M+12.62%
2024-05-29SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
21,700
0.0173%
$148.60$3.22M+81.51%
2019-04-08PurchaseCyclerion Therapeutics, Inc.
CYCN
director
626,117
0.1105%
$16.00$10.02M-46.83%
2013-05-15SalePfizer Inc.
PFE
Former Exec. Vice President
70,000
0.001%
$29.36$2.06M+3.97%
2013-02-06PurchaseZoetis Inc.
ZTS
director
5,000
0.0008%
$26.00$130,000+3.04%
2012-12-06SalePfizer Inc.
PFE
Former Exec. Vice President
100,000
0.0009%
$17.47$1.75M+13.94%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.